Pharma Companies to Share Data On Deadly Antimicrobial Resistance
Pharmaceutical companies have pledged to share surveillance data on new antimicrobial medicines such as antibiotics in a new register launched to combat antimicrobial resistance (AMR). Writing for SciDev.Net, Gilbert Nakweya reports that the initiative was launched on June 21, 2022, by Vivli , a non-profit clinical research data sharing organisation.
The initiative will enable scientists from all over the world to access data on epidemiological, physical and genetic characteristics of organisms and their resistance to various antibiotics.
Deaths attributed to antimicrobial resistance in 2019 were on a par with those linked to HIV and malaria combined, with Sub-Saharan Africa having the highest burden of AMR, according to a study published in The Lancet early this year. Antimicrobial resistance was linked directly to an estimated 1.27 million deaths globally, while HIV/AIDS and malaria directly accounted for 860,000 and 640,000 deaths respectively. Low- and middle-income countries are the worst affected.
The Covid-19 pandemic has exposed long-standing structural fault lines in societies - especially in health systems. These same inequalities drive another major gl Read more »
Antimicrobial resistance poses a significant threat to humanity, health leaders have warned, as a study reveals it has become a leading cause of death worldwide. Hundreds of ... Read more »
The leaders of six regional organisations in Africa are calling for stronger governance to fight antimicrobial resistance, or AMR, on the eve of World Antimicrobial Awareness Week, ... Read more »
A medical illustration of drug-resistant Mycobacterium tuberculosis bacteria (from the Centers for Disease Control and Prevention publication entitled Antibiotic Resistance Threats in the United States, 2019).